Obesity Drug Drives Proxy Fight
Vivus Cozies Up to Menarini on ED Drug, but Whither Qsymia?
By Marie Powers
Wednesday, July 10, 2013
After spending three months seeking to tamp down a proxy battle with shareholder First Manhattan Co. (FMC), Vivus Inc. got a bit of a lift Tuesday.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.